Recent Updates
Recently added Catalysts
BCAX Positive Sentiment

Bicara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Monday, February 24, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Bicara Therapeutics Inc. will be presenting at the TD Cowen 45th Annual Health Care Conference on March 3, 2025. Claire Mazumdar, the CEO, will lead the presentation, highlighting the company's focus on transformative bifunctional therapies for solid tumors. A live webcast of the event will be available, along with a replay for those unable to attend.
Price reaction · baseline $13 (2025-02-21 close) · clean, no other BCAX news in the window
day 0 close
-0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Bicara Therapeutics is actively engaging with the investment community.
  • The presentation signifies the company's commitment to innovation in solid tumor therapies.
  • Live webcast access enhances transparency and engagement with stakeholders.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+36%
120-day peak, hindsight
Typical move
12.1%
average across 2 past catalysts
Cash runway
~33 mo
Minimal dilution risk
Lead asset
Ficerafusp alfa
Phase 2 · Squamous Cell Carcinoma of Head and Neck (SCCHN)

Full Press Release Details

BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that Claire Mazumdar, PhD, MBA, Chief Executive Officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 3:10 p.m. ET.
A live webcast of the presentation will be available at Events and Presentations. A replay of the webcast will be archived and available following the event.
About Bicara Therapeutics

Frequently Asked Questions

When is Bicara Therapeutics presenting at the TD Cowen Conference?

Bicara Therapeutics will present on March 3, 2025, at 3:10 p.m. ET.

Who will present for Bicara Therapeutics at the conference?

Claire Mazumdar, PhD, MBA, will present at the conference.

Where can I watch the presentation live?

The presentation will be available live on the Events and Presentations page.

Will there be a replay available after the presentation?

Yes, a replay of the webcast will be archived post-event.

What is the focus of Bicara Therapeutics?

Bicara Therapeutics focuses on bifunctional therapies for solid tumors.

ShareAdd on Google
Tags: BCAX Viatris Investor Conferences Healthcare Bicara Therapeutics health care conference solid tumors biopharmaceuticals
Last updated: Feb 24, 2025

Biotech snapshot

Cash runway
$497M liquidity · $15M/mo burn
~33 mo
Minimal dilution risk
Lead asset
Ficerafusp alfaPhase 2
Squamous Cell Carcinoma of Head and Neck (SCCHN) →

Catalyst track record

+36%
best trade around BCAX's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for BCAX.

See every catalyst's timing & PoA →